Stocks Baird Raises Regenxbio Share Price Target to $39 Amid Positive Trial Data From Investing.comMarch 5, 2024 On Tuesday, Regenxbio Inc. (NASDAQ:RGNX) saw Baird raise its stock price target to $39.00 from…
